<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04854629</url>
  </required_header>
  <id_info>
    <org_study_id>Orthosis Spinomed active</org_study_id>
    <nct_id>NCT04854629</nct_id>
  </id_info>
  <brief_title>Effects of the &quot;Spinomed Active&quot; Orthosis on Chronic Back Pain in Women With Vertebral Fractures.</brief_title>
  <official_title>Effects of the &quot;Spinomed Active&quot; Orthosis on Chronic Back Pain in Women With Osteoporotic Vertebral Bone Fracture and Hyperkyphosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>medi GmbH &amp; Co. KG, Bayreuth, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Osteoporotic vertebral fractures often lead to postural changes, chronic spinal pain&#xD;
      conditions and limited functionality. Orthoses that straighten the spine have been shown in&#xD;
      studies to have a positive effect on pain, posture and the functional state of patients with&#xD;
      a fresh vertebral fracture.&#xD;
&#xD;
      The planned study investigates the effect of the orthosis &quot;Spinomed active&quot; in patients aged&#xD;
      ≥ 65 years with at least one non-acute osteoporotic vertebral fracture (at least 3 months&#xD;
      ago) and chronic back pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 7, 2021</start_date>
  <completion_date type="Anticipated">May 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial with two study groups in parallel: (1) Spinomed active orthosis or 16 weeks (2) non spinomed active orthosis control</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Outcomes assessor were unaware of participant status (i.e. spinomed active or control) and were not allowed to ask correspondingly</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Back pain</measure>
    <time_frame>At baseline and after 16 weeks (i.e. over 16 weeks)</time_frame>
    <description>Change in back pain (mean intensity over 4 weeks on the &quot;numeric pain scale (NPS) &quot;0-10&quot;).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Trunk strength/performance</measure>
    <time_frame>At baseline and after 16 weeks (i.e. over 16 weeks)</time_frame>
    <description>Changes of maximum dynamic trunk strength (index of trunk extension/flexion/lateral flexion) as determined by a dynamic testing device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kyphosis angle</measure>
    <time_frame>At baseline and after 16 weeks (i.e. over 16 weeks)</time_frame>
    <description>Changes of kyphosis angle as determined by angle measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional capacity</measure>
    <time_frame>At baseline and after 16 weeks (i.e. over 16 weeks)</time_frame>
    <description>Changes in Chair-Rise-Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function</measure>
    <time_frame>At baseline and after 16 weeks (i.e. over 16 weeks)</time_frame>
    <description>Changes in vital capacity as determined by a pulmonary function monitor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Everyday life skills</measure>
    <time_frame>At baseline and after 16 weeks (i.e. over 16 weeks)</time_frame>
    <description>Changes of everyday life skills as determined by a questionnaire (late-life function and disability instrument)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Balance capacity</measure>
    <time_frame>At baseline and after 16 weeks (i.e. over 16 weeks)</time_frame>
    <description>Changes in Body Sway as determined by a balance sensor device</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Osteopenia</condition>
  <condition>Kyphosis</condition>
  <arm_group>
    <arm_group_label>Spinomed active orthosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wearing the orthosis for 16 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention: non spinomed active control</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spinomed active</intervention_name>
    <description>Wearing of the orthosis 2-3 h/twice a day for 16 weeks Supplementation of a maximum of 1000 mg/d calcium and 800 IE/d vitamin D</description>
    <arm_group_label>Spinomed active orthosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Living independently in the community&#xD;
&#xD;
          -  ≥ 1 low-traumatic vertebral fracture ≥ 3 months ago&#xD;
&#xD;
          -  Chronic back pain according to the national guideline for low back pain&#xD;
&#xD;
          -  Mean back pain intensity NPS ≥ 1 (1-10 scale)&#xD;
&#xD;
          -  Hyperkyphosis, kyphosis angle according to Debrunner &gt;40°&#xD;
&#xD;
          -  Intact skin or adequate wound coverage in the area of the contact surface of the&#xD;
             orthosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Secondary osteoporosis (as determined by study physician)&#xD;
&#xD;
          -  Expected change in overall pain therapy during the study period&#xD;
&#xD;
          -  Structurally fixed kyphosis, lack of extension ability of the thoracic spine&#xD;
&#xD;
          -  Kyphoplasty, vertebroplasty&#xD;
&#xD;
          -  Use of back orthoses during the last 6 months&#xD;
&#xD;
          -  Depression&#xD;
&#xD;
          -  Dementia, cognitive impairment (Mini Mental Test &lt; 25)&#xD;
&#xD;
          -  Fresh neurological deficits; incontinence &gt; grade 1&#xD;
&#xD;
          -  Body dimensions that do not allow for adjustment of the back orthosis&#xD;
&#xD;
          -  Absence during baseline and follow-up assessments&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Higher incidence of osteopenia in female population</gender_description>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolfgang Kemmler, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Institute of Medical Physics, Friedrich-Alexander University of Erlangen-Nürnberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Medical Physics University of Erlangen-Nurnberg</name>
      <address>
        <city>Erlangen</city>
        <zip>91052</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2021</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
    <mesh_term>Kyphosis</mesh_term>
    <mesh_term>Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data that support the findings of this study are available on request from the corresponding researcher (SW)</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data will become available in March 2022 without time limit.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

